• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Liver stereotactic ablative radiotherapy: an effective and feasible alternative to surgery during the COVID-19 pandemic

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    32387045.pdf
    Size:
    137.8Kb
    Format:
    PDF
    Description:
    From UNPAYWALL
    Download
    Authors
    Aitken, K.
    Good, J.
    Hawkins, M.
    Grose, D.
    Mukherjee, S.
    Harrison, M.
    Radhakrishna, Ganesh
    Affiliation
    The Royal Marsden NHS Foundation Trust, London, UK.
    Issue Date
    2020
    
    Metadata
    Show full item record
    Abstract
    The COVID-19 pandemic is having an unprecedented impact on UK cancer services. Access to radical surgery has been severely restricted and resources for systemic therapy provision are being limited as the crisis unfolds. Radiotherapy resources are rightly being focused on patients being treated with curative intent. However, it is our experience that access to stereotactic ablative radiotherapy (SABR) is diminishing, predominantly due to staffing shortages. SABR offers a non-invasive, outpatient ablative approach with minimal hospital footfall and with lower immunosuppressive risks than chemotherapy. The recently published long-term outcomes of the SABR COMET study illustrate the ability of SABR to substantially impact survival across tumour types [1]. The NHS England Commissioning through Evaluation process has shown that SABR can be safely delivered in the UK [2,3]. SABR requires specialist multidisciplinary expertise. The majority of radiotherapy departments are planning to maintain their capacity for category 1?4 treatments [4] and many have therefore suspended SABR for oligometastatic disease. However, we are concerned that diminishing access to SABR, at a time when access to other curative local treatment modalities is already restricted, will result in poorer patient outcomes in the short and medium term when this need not be the case. Patients with liver-limited colorectal cancer have a 5-year survival of 40% following surgery [5]. Given the evidence supporting SABR for colorectal liver metastases [6], we believe that this should be prioritised if patients are unable to access surgery and interventional ablative techniques. Similarly, SABR should be considered for patients with hepatocellular carcinoma while access to other services (particularly transplant) is limited. We urge radiotherapy departments to preserve access to SABR for patients in these situations, particularly as the COVID-19 pandemic wanes and staffing levels allow the re-establishment of normal services.
    Citation
    K. Aitken, J. Good, M. Hawkins et al. Liver Stereotactic Ablative Radiotherapy: an Effective and Feasible Alternative to Surgery during the COVID-19 Pandemic. Clin Oncol (R Coll Radiol). 2020
    Journal
    Clinical Oncology
    URI
    http://hdl.handle.net/10541/623015
    DOI
    10.1016/j.clon.2020.04.012
    PubMed ID
    32387045
    Additional Links
    https://dx.doi.org/10.1016/j.clon.2020.04.012
    Type
    Article
    Language
    en
    ae974a485f413a2113503eed53cd6c53
    10.1016/j.clon.2020.04.012
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Radiotherapy and Systemic Treatment for Non-melanoma Skin Cancer in the COVID-19 Pandemic.
    • Authors: Rembielak A, Sykes AJ, Fife K, Challapalli A, Nobes JP
    • Issue date: 2020 Jul
    • COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy.
    • Authors: Jereczek-Fossa BA, Palazzi MF, Soatti CP, Cazzaniga LF, Ivaldi GB, Pepa M, Amadori M, Antognoni P, Arcangeli S, Buffoli A, Beltramo G, Berlinghieri S, Bignardi M, Bracelli S, Bruschieri L, Castiglioni S, Catalano G, Di Muzio N, Fallai C, Fariselli L, Filippi AR, Gramaglia A, Italia C, Lombardi F, Magrini SM, Nava S, Orlandi E, Pasinetti N, Sbicego EL, Scandolaro L, Scorsetti M, Stiglich F, Tonoli S, Tortini R, Valdagni R, Vavassori V, Marvaso G, CODRAL (Board of Directors of Radiation Oncology Departments in Lombardy) network
    • Issue date: 2020 Jul
    • Lymphocytopenia and Radiotherapy Treatment Volumes in the Time of COVID-19.
    • Authors: Joseph N, Choudhury A
    • Issue date: 2020 Jul
    • A recommendation for IVF lab practice in light of the current COVID-19 pandemic.
    • Authors: Arav A
    • Issue date: 2020 Jul
    • The Virtual Scientific Sessions from the American Society of Breast Surgeons During the COVID-19 Pandemic.
    • Authors: Kuerer HM, Blair SL
    • Issue date: 2020 Nov
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.